| Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans Journal of British Surgery 107 (11), 1440-1449, 2020 | 1146 | 2020 |
| Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle-and high-income countries BJA: British Journal of Anaesthesia 117 (5), 601-609, 2016 | 500 | 2016 |
| Elective surgery cancellations due to the COVID‐19 pandemic: global predictive modelling to inform surgical recovery plans CovidSurg Collaborative, D Nepogodiev, OM Omar, JC Glasbey, E Li, ... British journal of surgery 107 (11), 1440-1449, 2020 | 354 | 2020 |
| Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study) K Kumar, R North, R Taylor, M Sculpher, C Van den Abeele, M Gehring, ... Neuromodulation: Technology at the Neural Interface 8 (4), 213-218, 2005 | 198 | 2005 |
| Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study C Perruchoud, S Eldabe, AM Batterham, G Madzinga, M Brookes, ... Neuromodulation: Technology at the Neural Interface 16 (4), 363-369, 2013 | 178 | 2013 |
| Does a screening trial for spinal cord stimulation in patients with chronic pain of neuropathic origin have clinical utility and cost-effectiveness (TRIAL-STIM)? A randomised … S Eldabe, RV Duarte, A Gulve, S Thomson, G Baranidharan, R Houten, ... Pain 161 (12), 2820-2829, 2020 | 67 | 2020 |
| Ziconotide monotherapy: a systematic review of randomised controlled trials ME Brookes, S Eldabe, A Batterham Current Neuropharmacology 15 (2), 217-231, 2017 | 58 | 2017 |
| The effectiveness and cost-effectiveness of spinal cord stimulation for refractory angina (RASCAL study): a pilot randomized controlled trial S Eldabe, S Thomson, R Duarte, M Brookes, M Debelder, J Raphael, ... Neuromodulation: Technology at the Neural Interface 19 (1), 60-70, 2016 | 49 | 2016 |
| Bolus Intrathecal Injection of Ziconotide (P rialt®) to Evaluate the Option of Continuous Administration via an Implanted Intrathecal Drug Delivery (ITDD) System: A Pilot Study SI Mohammed, S Eldabe, KH Simpson, M Brookes, G Madzinga, A Gulve, ... Neuromodulation: Technology at the Neural Interface 16 (6), 576-582, 2013 | 45 | 2013 |
| Prospective analysis of the trial period for spinal cord stimulation treatment for chronic pain M Chincholkar, S Eldabe, R Strachan, M Brookes, F Garner, R Chadwick, ... Neuromodulation: Technology at the Neural Interface 14 (6), 523-529, 2011 | 45 | 2011 |
| Effects of flow rate modifications on reported analgesia and quality of life in chronic pain patients treated with continuous intrathecal drug therapy C Perruchoud, S Eldabe, A Durrer, M Bovy, M Brookes, G Madzinga, ... Pain Medicine 12 (4), 571-576, 2011 | 28 | 2011 |
| To trial or not to trial before spinal cord stimulation for chronic neuropathic pain: the patients’ view from the TRIAL-STIM randomized controlled trial R Chadwick, R McNaughton, S Eldabe, G Baranidharan, J Bell, ... Neuromodulation: Technology at the Neural Interface 24 (3), 459-470, 2021 | 24 | 2021 |
| Does a screening trial for spinal cord stimulation in patients with chronic pain of neuropathic origin have clinical utility and cost-effectiveness?(TRIAL-STIM study): study … S Eldabe, A Gulve, S Thomson, G Baranidharan, R Duarte, S Jowett, ... Trials 19, 1-11, 2018 | 21 | 2018 |
| Impact of the National Institute for Health and Care Excellence (NICE) guidance on medical technology uptake: analysis of the uptake of spinal cord stimulation in England 2008–2012 B Vyawahare, N Hallas, M Brookes, RS Taylor, S Eldabe BMJ open 4 (1), e004182, 2014 | 20 | 2014 |
| An exploration of the experiences and educational needs of patients with failed back surgery syndrome receiving spinal cord stimulation CG Ryan, S Eldabe, R Chadwick, SE Jones, HL Elliott-Button, M Brookes, ... Neuromodulation: Technology at the Neural Interface 22 (3), 295-301, 2019 | 15 | 2019 |
| Analgesic efficacy of “burst” and tonic (500 Hz) spinal cord stimulation patterns: a randomized placebo-controlled crossover study S Eldabe, R Duarte, A Gulve, H Williams, F Garner, M Brookes, ... Neuromodulation: Technology at the Neural Interface 24 (3), 471-478, 2021 | 13 | 2021 |
| Does a screening trial for spinal cord stimulation in patients with chronic pain of neuropathic origin have clinical utility (TRIAL-STIM)? 36-Month results from a randomized … S Eldabe, S Nevitt, S Griffiths, A Gulve, S Thomson, G Baranidharan, ... Neurosurgery 92 (1), 75-82, 2023 | 11 | 2023 |
| A prospective long-term follow-up of dorsal root ganglion stimulation for the management of chronic intractable pain S Eldabe, S Copley, A Gulve, G Baranidharan, B Bretherton, A Kansal, ... Pain 163 (4), 702-710, 2022 | 8 | 2022 |
| Screening trials of spinal cord stimulation for neuropathic pain in england—a budget impact analysis RV Duarte, R Houten, S Nevitt, M Brookes, J Bell, J Earle, A Gulve, ... Frontiers in Pain Research 3, 974904, 2022 | 7 | 2022 |
| Ziconotide for severe neuropathic pain in metastatic breast cancer S Mohammed, ME Brookes, S Eldabe Journal of Pain & Palliative Care Pharmacotherapy 26 (3), 286-288, 2012 | 7 | 2012 |
